News

“Our present data reinforce knowledge about an age-related alteration in the synthesis of major proteins linked to the migratory and contractile functions of dermal human fibroblasts.” Credit: © 2024 Boismal et al. “Our present data reinforce knowledge about an age-related alteration in the synthesis of

With a generous donation from the Li Ka Shing Foundation, the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) will be the first institution in Asia to introduce the groundbreaking Histotripsy system, using state-of-the-art histotripsy technology for clinical trials, offering Hong Kong

New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and

In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the closest neighbors of breast cancer cells that are likely to spread. The researchers say the finding, focused on a white blood

Researchers at WEHI (Melbourne, Australia) have identified a promising new two-in-one treatment that not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defence against it. Credit: WEHI Researchers at WEHI (Melbourne, Australia) have identified a promising

An Aston University researcher has used light to develop the first step towards a quicker, cheaper and less painful technique to detect cancer.  Professor Igor Meglinski from the University’s Aston Institute of Photonic Technologies led the team that has developed a new method of analysing

Researchers at the Centre for Genomic Regulation (CRG) have discovered hundreds of potential new cancer driver genes. The findings, published in the journal Nature Communications, significantly expands the list of possible therapeutic targets to monitor and tackle the disease. Credit: Miquel Anglada Girotto/Centro de Regulación

  Credit: VHIO Published open access in Genome Medicine, results of a study led by VHIO’s Experimental Therapeutics Group further support the use of selective PARP1 inhibitors in tumors with genetic alterations in BRCA1/2.   Findings show that the PARP1 selective inhibitor saruparib elicited superior

Acute lung injury (ALI), marked by the sudden onset of widespread lung inflammation, severely impairs gas exchange function in the lungs and can progress to acute respiratory distress syndrome (ARDS). ARDS, a more severe and often fatal disorder, is characterized by widespread alveolar damage, compromised

Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are diagnosed annually. While reducing testosterone and other male hormones can be an effective treatment for prostate cancer, this approach becomes ineffective